New Zealand markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
353.18+0.15 (+0.04%)
At close: 04:01PM EDT
360.19 +7.01 (+1.98%)
After hours: 05:02PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
434,215
470,783
662,205
660,672
Other short-term investments
1,362,017
404,695
334,473
459,533
Total cash
1,796,232
875,478
996,678
1,120,205
Net receivables
494,645
423,537
419,424
392,672
Inventory
719,316
572,239
622,253
554,007
Other current assets
147,783
117,834
101,480
113,271
Total current assets
3,157,976
1,989,088
2,139,835
2,180,155
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
679,564
695,750
693,507
701,207
Accumulated depreciation
-1,009,408
-997,616
-961,390
-882,833
Net property, plant and equipment
679,564
695,750
693,507
701,207
Equity and other investments
8,830,892
14,387,006
9,561,140
4,638,205
Goodwill
406,488
347,343
291,916
264,131
Intangible assets
332,147
253,939
199,497
145,525
Other long-term assets
94,599
102,669
86,723
79,636
Total non-current assets
10,343,690
15,786,707
10,832,783
5,828,704
Total assets
13,501,666
17,775,795
12,972,618
8,008,859
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
465
489
1,798
426,172
Accounts payable
329,831
418,927
362,326
287,098
Taxes payable
11,929
10,319
23,282
8,763
Accrued liabilities
194,790
276,986
222,875
180,084
Deferred revenues
52,211
50,852
42,468
33,735
Other current liabilities
205,984
215,223
210,077
155,940
Total current liabilities
568,708
680,938
631,536
905,495
Non-current liabilities
Long-term debt
1,197,716
10,514
12,258
13,579
Deferred tax liabilities
1,770,481
3,059,080
2,076,785
997,787
Other long-term liabilities
2,119,990
3,417,209
2,448,884
1,334,728
Total non-current liabilities
3,317,706
3,427,723
2,461,142
1,348,307
Total liabilities
3,886,414
4,108,661
3,092,678
2,253,802
Stockholders' equity
Common stock
3
3
3
3
Retained earnings
9,898,203
13,507,241
9,268,012
5,470,779
Accumulated other comprehensive income
-466,822
-175,553
282,456
-87,348
Total stockholders' equity
9,615,252
13,667,134
9,879,940
5,755,057
Total liabilities and stockholders' equity
13,501,666
17,775,795
12,972,618
8,008,859